{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:32:00Z","timestamp":1768480320488,"version":"3.49.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T00:00:00Z","timestamp":1438128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134392","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T18:07:48Z","timestamp":1438193268000},"page":"e0134392","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy"],"prefix":"10.1371","volume":"10","author":[{"given":"Devy","family":"Deliyanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay","family":"Khong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Berka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Wilkinson-Berka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"JW Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"DA Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"ref3","first-page":"642","article-title":"Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid","volume":"147","author":"DS McLeod","year":"1995","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","volume":"18","author":"AM Joussen","year":"2004","journal-title":"FASEB J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S0952523800173122","article-title":"Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats","volume":"17","author":"XX Zeng","year":"2000","journal-title":"Vis Neurosci"},{"key":"ref6","first-page":"1971","article-title":"Glial reactivity, an early feature of diabetic retinopathy","volume":"41","author":"E Rungger-Brandle","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"A Bringmann","year":"2006","journal-title":"Prog Retin Eye Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2337\/diabetes.47.3.445","article-title":"Muller cell changes in human diabetic retinopathy","volume":"47","author":"M Mizutani","year":"1998","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"F Giacco","year":"2010","journal-title":"Circ Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/dmrr.431","article-title":"The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy","volume":"20","author":"TM Curtis","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.2174\/09298673113209990025","article-title":"Advanced glycation end products and diabetic retinopathy","volume":"20","author":"M Chen","year":"2013","journal-title":"Curr Med Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.peptides.2012.04.008","article-title":"The retinal renin-angiotensin system: roles of angiotensin II and aldosterone","volume":"36","author":"JL Wilkinson-Berka","year":"2012","journal-title":"Peptides"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/db10-0552","article-title":"Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function","volume":"59","author":"AG Miller","year":"2010","journal-title":"Diabetes"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1097\/00004872-198812040-00145","article-title":"Association of high plasma prorenin with diabetic retinopathy","volume":"6","author":"AA Franken","year":"1988","journal-title":"J Hypertens Suppl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9440(10)63806-0","article-title":"The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies","volume":"162","author":"CJ Moravski","year":"2003","journal-title":"Am J Pathol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-68-1-160","article-title":"Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy","volume":"68","author":"AH Danser","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(95)05607-6","article-title":"Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"118","author":"K Miyazawa","year":"1995","journal-title":"Atherosclerosis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"H2860","DOI":"10.1152\/ajpheart.01167.2006","article-title":"Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy","volume":"293","author":"DJ Kelly","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"p83","DOI":"10.1159\/000074845","article-title":"Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy","volume":"95","author":"S Mifsud","year":"2003","journal-title":"Nephron Physiol"},{"key":"ref20","first-page":"459","article-title":"Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat","volume":"40","author":"Y Takehana","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1167\/iovs.09-4161","article-title":"Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCAM-1 in human corneal fibroblasts","volume":"51","author":"T Adachi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1016\/j.bmcl.2009.09.120","article-title":"Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates","volume":"19","author":"SC Zammit","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/eurjhf\/hfs011","article-title":"FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy","volume":"14","author":"Y Zhang","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e47160","DOI":"10.1371\/journal.pone.0047160","article-title":"A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat","volume":"7","author":"RE Gilbert","year":"2012","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/344541a0","article-title":"Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene","volume":"344","author":"JJ Mullins","year":"1990","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1167\/iovs.06-0892","article-title":"Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol","volume":"48","author":"JA Phipps","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjhyper.2006.09.018","article-title":"Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina","volume":"20","author":"JL Wilkinson-Berka","year":"2007","journal-title":"Am J Hypertens"},{"key":"ref28","first-page":"183","article-title":"Safety of intravitreal voriconazole: electroretinographic and histopathologic studies","volume":"101","author":"H Gao","year":"2003","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1089\/ars.2013.5357","article-title":"NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy","volume":"20","author":"JL Wilkinson-Berka","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/ATVBAHA.114.303792","article-title":"Retinal Vasculopathy Is Reduced by Dietary Salt Restriction: Involvement of Glia, ENaCalpha, and the Renin-Angiotensin-Aldosterone System","volume":"34","author":"D Deliyanti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"JL Wilkinson-Berka","year":"2009","journal-title":"Circ Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cardiores.2007.06.022","article-title":"Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat","volume":"76","author":"KA Connelly","year":"2007","journal-title":"Cardiovasc Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1523-1755.1998.00019.x","article-title":"A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)","volume":"54","author":"DJ Kelly","year":"1998","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.36.6.1099","article-title":"Retinal neovascularization is prevented by blockade of the renin-angiotensin system","volume":"36","author":"CJ Moravski","year":"2000","journal-title":"Hypertension"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/CS20120212","article-title":"Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy","volume":"124","author":"JL Wilkinson-Berka","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2217\/imt.11.24","article-title":"Anti-inflammatory therapy for diabetic retinopathy","volume":"3","author":"W Zhang","year":"2011","journal-title":"Immunotherapy"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2337\/diabetes.54.5.1534","article-title":"Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas","volume":"54","author":"SY Kim","year":"2005","journal-title":"Diabetes"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","article-title":"Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition","volume":"96","author":"K Miyamoto","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/1440-1681.12099","article-title":"Brain And Retinal Microglia In Health And Disease: An Unrecognized Target Of The Renin-Angiotensin System","volume":"40","author":"CA McCarthy","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref40","first-page":"3561","article-title":"Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group","volume":"41","author":"AJ Barber","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1167\/iovs.06-0478","article-title":"Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation","volume":"47","author":"T Kurihara","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e100954","DOI":"10.1371\/journal.pone.0100954","article-title":"Combined renin inhibition\/(pro)renin receptor blockade in diabetic retinopathy\u2014a study in transgenic (mREN2)27 rats","volume":"9","author":"WW Batenburg","year":"2014","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00125-010-1900-z","article-title":"Hyperglycaemia-induced pro-inflammatory responses by retinal Muller glia are regulated by the receptor for advanced glycation end-products (RAGE)","volume":"53","author":"H Zong","year":"2010","journal-title":"Diabetologia"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1073\/pnas.0608167104","article-title":"Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis","volume":"104","author":"T Nakazawa","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1074\/jbc.M805464200","article-title":"Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells","volume":"284","author":"MD Shelton","year":"2009","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1167\/iovs.12-10410","article-title":"Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines","volume":"53","author":"SD Schoenberger","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ajo.2011.02.014","article-title":"Intraocular oxygen distribution in advanced proliferative diabetic retinopathy","volume":"152","author":"CA Lange","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"ref48","first-page":"605946","article-title":"Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy","volume":"2015","author":"J He","year":"2015","journal-title":"Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"EA Pierce","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/db09-1420","article-title":"Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage","volume":"59","author":"J Wang","year":"2010","journal-title":"Diabetes"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1056-8727(01)00155-6","article-title":"Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy","volume":"15","author":"T Yuuki","year":"2001","journal-title":"J Diabetes Complications"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ijc.20871","article-title":"Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1","volume":"115","author":"S Loeffler","year":"2005","journal-title":"Int J Cancer"},{"key":"ref53","first-page":"106594","article-title":"Animal models of diabetic retinopathy: summary and comparison","volume":"2013","author":"AK Lai","year":"2013","journal-title":"J Diabetes Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.2337\/diabetes.51.9.2826","article-title":"The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes","volume":"51","author":"A Stitt","year":"2002","journal-title":"Diabetes"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T21:30:59Z","timestamp":1567027859000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134392"}},"subtitle":[],"editor":[{"given":"Michael E","family":"Boulton","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,29]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134392","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,29]]}}}